Christina Isacson is a Partner at Lightstone Ventures focusing on biopharmaceutical investments. She has experience in venture capital and operational roles within the biotechnology industry.
At firms with a similar stage, sector and check size.

One email when Christina's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckChristina Isacson is a Partner at Lightstone Ventures focusing on biopharmaceutical investments. She has experience in venture capital and operational roles within the biotechnology industry.
Lightstone Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder Lightstone Ventures backed works best.
Boston University’s Technology Development Fund; Accelerator Corp (Fund I); Ironwood Pharmaceuticals (NASDAQ:IRWD); Principal at Third Rock Ventures; Chief Business Officer at Magenta Therapeutics (NASDAQ:MGTA).
Last updated 2026-10-15. Is this you? Ask for a correction.